118 related articles for article (PubMed ID: 38700108)
1. CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R/STAT3 axis.
Dai Y; Ji Z; Liang H; Jiang M; Wang L; Bao X; Liu J; Liu M; Yang C
Cancer Sci; 2024 May; ():. PubMed ID: 38700108
[TBL] [Abstract][Full Text] [Related]
2. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative Breast Cancer.
Tang C; Jiang ST; Li CX; Jia XF; Yang WL
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611749
[TBL] [Abstract][Full Text] [Related]
4. IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.
Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
[TBL] [Abstract][Full Text] [Related]
5. SILAC proteomics based on 3D cell spheroids unveils the role of RAC2 in regulating the crosstalk between triple-negative breast cancer cells and tumor-associated macrophages.
Guo Y; Deng X; Wang S; Yuan Y; Guo Z; Hao H; Jiao Y; Li P; Han S
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127639. PubMed ID: 37879580
[TBL] [Abstract][Full Text] [Related]
6. VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.
Wang L; Zhang L; Zhao L; Shao S; Ning Q; Jing X; Zhang Y; Zhao F; Liu X; Gu S; Zhao X; Luo M
Int J Biol Sci; 2024; 20(2):446-463. PubMed ID: 38169627
[TBL] [Abstract][Full Text] [Related]
7. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE.
Qiao J; Chen Y; Mi Y; Jin H; Wang L; Huang T; Li H; Song Y; Cao J; Wu B; Wang Q; Zou Z
Biochem Pharmacol; 2020 Oct; 180():114126. PubMed ID: 32603665
[TBL] [Abstract][Full Text] [Related]
8. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract][Full Text] [Related]
9. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
[TBL] [Abstract][Full Text] [Related]
10. Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages.
Mei M; Tang L; Zhou H; Xue N; Li M
Eur J Pharmacol; 2023 Nov; 959():176076. PubMed ID: 37797675
[TBL] [Abstract][Full Text] [Related]
11. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.
Chen Z; Wu J; Wang L; Zhao H; He J
Med Oncol; 2022 May; 39(5):83. PubMed ID: 35570226
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
Pe KCS; Saetung R; Yodsurang V; Chaotham C; Suppipat K; Chanvorachote P; Tawinwung S
PLoS One; 2022; 17(8):e0273044. PubMed ID: 35960749
[TBL] [Abstract][Full Text] [Related]
15. HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.
Ramos Solis N; Cannon A; Dilday T; Abt M; Oblak AL; Soloff AC; Kaplan MH; Yeh ES
Oncoimmunology; 2024; 13(1):2364382. PubMed ID: 38846083
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
[TBL] [Abstract][Full Text] [Related]
17. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.
Parveen S; Siddharth S; Cheung LS; Kumar A; Shen J; Murphy JR; Sharma D; Bishai WR
Mol Oncol; 2021 May; 15(5):1330-1344. PubMed ID: 33682324
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
[TBL] [Abstract][Full Text] [Related]
20. G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.
Li Y; Han X; Lin Z; Wang C; Fu Z; Sun Q; Li C
Cell Mol Life Sci; 2023 May; 80(6):165. PubMed ID: 37237244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
